Skip to content

Clinical trials

Carcinoma, Squamous Cell trials in India

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Squamous Cell Country / region: India Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20082
20091
20101
20161
20191
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated4
Recruiting2
Unknown status2
Completed1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
All India Institute of Medical Sciences1
AstraZeneca1
Boston Scientific Corporation1
HealthCare Global Enterprise Ltd.1
Johnson & Johnson Enterprise Innovation Inc.1
Merck KGaA, Darmstadt, Germany1
Olgun Elicin1
Pfizer1
Sesen Bio, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Squamous Cell9
Neoplasms, Squamous Cell3
Squamous Cell Carcinoma of Head and Neck3
Esophageal Neoplasms2
Head and Neck Neoplasms2
Carcinoma in Situ1
Carcinoma, Adenosquamous1
Carcinoma, Large Cell1
Carcinoma, Non-Small-Cell Lung1
Esophageal Squamous Cell Carcinoma1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.